Recurrent arthritis as an unexpected side effect associated with azacitidine in a patient with myelodysplastic syndrome
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, vol.28, no.2, pp.500-503, 2022 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 28 Issue: 2
- Publication Date: 2022
- Doi Number: 10.1177/10781552211049728
- Journal Name: JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
- Page Numbers: pp.500-503
- Keywords: azacitidine, demethylating agent, myelodysplastic syndrome, arthritis, crystal-induced arthritis, AGENTS
- Akdeniz University Affiliated: Yes
Abstract
Introduction Hypomethylating agents have confirmed efficacy for myelodysplastic syndrome and acute myeloid leukemia and are widely used. Although arthralgia is common side effect associated with hypomethylating agents, arthritis has not been reported previously.